PPH — VanEck Pharmaceutical ETF price, holdings and performance

NASDAQ·Exchange Traded Fund·US Equities·US

Latest market price

112.30

+1.14+1.02%

Overview Short InterestFilings

PPHVanEck Pharmaceutical ETF·NASDAQ

Overview Short InterestFilings

112.30+1.02%

Loading chart...

Screen all →

VXUS-0.35%$86.91 VUG-0.22%$89.20 VTV+0.33%$225.06 VO+0.18%$82.83 VB-0.17%$305.56 VGT-0.44%$120.91 VWO-0.12%$60.40 SPCK+1.20%$22.28

Fund Snapshot

Category	-	Asset Type	Equity	Tags	healthcare	Return% 1Y	36.69%	Total Holdings	26	Perf Week	0.69%

Sponsor	VanEck	ETF Type		Tags	sector	Return% 3Y	13.72%	AUM	$966.15M	Perf Month	1.40%

Fund Family		Bond Type		Tags	-	Return% 5Y	10.17%	NAV/sh		Perf Quarter	10.24%

Index	-	Average Maturity		Tags	-	Return% 10Y		52W High	115.75 -2.98%	Perf Half Y	3.08%

Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	82.58 35.99%	Perf YTD	7.74%

Active/Passive		Quant Type		Tags	-	Flows% 1M	0.00%	Volatility	1.90% 1.57%	Perf Year	32.59%

Dividend TTM	2.17 (1.93%)	ESG Type		Tags	-	Flows% 3M	0.25%	ATR (14)	2.08	Perf 3Y	39.18%

Dividend Ex-Date	Jul 01, 2026	Dividend Type		Sector/Theme		Flows% YTD	1.55%	RSI (14)	55.45	Perf 5Y	48.49%

Dividend Gr. 3/5Y	-	Structure Type		Region		Flows% 1Y		Beta	0.44	Perf 10Y	80.13%

Expense	0.36%	Growth/Value		SMA20	1.14%	Flows% 3Y		Rel Volume	0.27	Prev Close	111.16

Inverse/Leveraged		Market Cap		SMA50	3.09%	Flows% 5Y		Avg Volume	265.13K	Price	112.30

IPO Date	Dec 20, 2011	Option/Short	Yes / Yes	SMA200	6.84%	52W Range %	90%	Volume	70,995	Change	1.02%

Assets Under Management

● Assets Under Management

Latest News

Aug-05-26

Aug-05-2607:21AM

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?zacks.com

Jul-30-26

Jul-30-2604:35AM

Some More Notes On Pharmaceutical TariffsSeekingAlpha

Jul-26-26

Jul-26-2601:01PM

Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?fool.com

Jul-24-26

Jul-24-2606:25AM

Two Years to Build or Pay 200% — Which US Pharma Stocks Win?Benzinga

Jul-22-26

Jul-22-2611:53PM

Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJfool.com

Jul-20-26

Jul-20-2610:44AM

For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?fool.com

Jul-18-26

Jul-18-2601:03PM

AI Bubble Risks Make Dividend Stocks Attractive Againseekingalpha.com

Jul-17-26

Jul-17-2608:50AM

The Next Big Theme: July 2026SeekingAlpha

Jul-10-26

Jul-10-2602:30AM

Healthcare Investing: Finding Growth Beyond PharmaceuticalsSeekingAlpha

Jul-09-26

Jul-09-2608:15AM

Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?fool.com

Jul-08-26

Jul-08-2611:01AM

4 ETF Winners of June Likely to Gain in Julyzacks.com

Jul-07-26

Jul-07-2605:25PM

Namib Minerals Announces Board and Executive Leadership Appointments to Support Next Phase of Growthglobenewswire.com

Jul-04-26

Jul-04-2604:11PM

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?fool.com

Jun-29-26

Jun-29-2605:20PM

Biotech Is The Rate Cut Trade In DisguiseSeekingAlpha

05:00PM

Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address Itseekingalpha.com

Fund

VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR